0.00
price down icon100.00%   -2.27
 
loading
Schlusskurs vom Vortag:
$2.27
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$227.15M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-299.80M
KGV:
0.00
EPS:
-2.84
Netto-Cashflow:
$-217.49M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
Value
$0.00
$0.00
1-Wochen-Bereich:
Value
$0.00
$0.00
52-Wochen-Spanne:
Value
$0.00
$6.52

Acelyrin Inc Stock (SLRN) Company Profile

Name
Firmenname
Acelyrin Inc
Name
Telefon
805-456-4393
Name
Adresse
4149 LIBERTY CANYON RD., AGOURA HILLS
Name
Mitarbeiter
83
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
SLRN's Discussions on Twitter

Vergleichen Sie SLRN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SLRN
Acelyrin Inc
0.00 227.15M 0 -299.80M -217.49M -2.84
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
374.98 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
569.90 60.58B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
418.91 54.99B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
674.90 42.25B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
307.23 32.93B 3.81B -644.79M -669.77M -6.24

Acelyrin Inc Stock (SLRN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-08-14 Herabstufung H.C. Wainwright Buy → Neutral
2024-07-08 Hochstufung Wells Fargo Equal Weight → Overweight
2023-12-13 Eingeleitet Wells Fargo Equal Weight
2023-12-08 Eingeleitet Citigroup Neutral
2023-09-13 Herabstufung Morgan Stanley Overweight → Equal-Weight
2023-09-05 Eingeleitet H.C. Wainwright Buy
2023-05-30 Eingeleitet Jefferies Buy
2023-05-30 Eingeleitet Morgan Stanley Overweight
2023-05-30 Eingeleitet Piper Sandler Overweight
2023-05-30 Eingeleitet TD Cowen Outperform
Alle ansehen

Acelyrin Inc Aktie (SLRN) Neueste Nachrichten

pulisher
Aug 04, 2025

What are analysts’ price targets for Acelyrin Inc. in the next 12 monthsInvest like a pro with expert recommendations - Jammu Links News

Aug 04, 2025
pulisher
Aug 03, 2025

How does Acelyrin Inc. compare to its industry peersInvest confidently with professional guidance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is it the right time to buy Acelyrin Inc. stockTurn market volatility into profit opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What markets is Acelyrin Inc. expanding into Is SEVN stock a good long term investment option - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Acelyrin Inc. stockSky-high return potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of Acelyrin Inc. stockFree Expert Stock Watchlist - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive Acelyrin Inc. stock higher in 2025Master stock selection with insider knowledge - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Acelyrin Inc. stock overvalued or undervaluedBuild wealth faster with disciplined trading - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Acelyrin Inc. stock in 2025Exceptional stock performance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is Acelyrin Inc. stock compared to the marketCapitalize on emerging market opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Why is Acelyrin Inc. stock attracting strong analyst attentionBuild a diversified portfolio for risk management - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

How does Acelyrin Inc. generate profit in a changing economyPre Market Trend Scanner From AI Tools - Jammu Links News

Aug 01, 2025
pulisher
Jul 31, 2025

What are the technical indicators suggesting about Acelyrin Inc.Post Market Outlook For Every Investor - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 30, 2025

What is the risk reward ratio of investing in Acelyrin Inc. stockWealth Building Growth Plan For Consistent Profits - Jammu Links News

Jul 30, 2025
pulisher
Jul 29, 2025

Alumis (ALMS) Merges with ACELYRIN - Insider Monkey

Jul 29, 2025
pulisher
Jul 29, 2025

Sentiment Tools Show Shift in Trader Mood on Acelyrin Inc.AI Screening for Swing Trade Picks Finds Momentum - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Fibonacci Support Holding Strong in Acelyrin Inc.Secure Capital Picks With Upside Potential Tracked - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

What makes Acelyrin Inc. stock price move sharplyReliable Alerts for Daily Stock Movers Released - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 22:52:55 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

How many analysts rate Acelyrin Inc. as a “Buy”Entry Signal Trend Scanner For Fast Growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Acelyrin Inc. Company’s Quarterly Earnings Growth: What the Numbers SayReliable High Profit Alerts - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

Is Acelyrin Inc. Stock a Smart Buy in 2025 Investment Analysis InsideBig Profit Small Risk Alerts - beatles.ru

Jul 27, 2025
pulisher
Jul 25, 2025

What drives Acelyrin Inc. stock priceFree Predictions - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Acelyrin Inc. a good long term investmentExceptional profit velocity - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Does Acelyrin Inc. stock pay reliable dividendsConsistent wealth multiplication - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 23, 2025

Acelyrin Inc. Stock Analysis and ForecastExplosive wealth accumulation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Acelyrin Inc. stockTriple-digit wealth increases - Autocar Professional

Jul 23, 2025

Finanzdaten der Acelyrin Inc-Aktie (SLRN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.72
price down icon 0.40%
$37.91
price up icon 0.08%
$111.61
price up icon 0.33%
$29.13
price down icon 0.65%
$111.07
price up icon 0.95%
biotechnology ONC
$307.23
price up icon 0.96%
Kapitalisierung:     |  Volumen (24h):